Global Microneedle Flu Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 221322
  • calendar_today Published On: Jun, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Microneedle Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Microneedle Flu Vaccine size is estimated to be xx million in 2021 from USD XX million in 2020, with a change of XX% between 2020 and 2021. The global Microneedle Flu Vaccine market size is expected to grow at a CAGR of XX% for the next five years.

Market segmentation

Microneedle Flu Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Solid Microneedle

Hollow Microneedle

Coated Microneedle

Dissolving Microneedle

Market segment by Application can be divided into

Influenza A

Influenza B

The key market players for global Microneedle Flu Vaccine market are listed below:

Sanofi

GC Pharma

Debiotech

NanoPass Technologies

Corium International

Becton Dickinson and Company

FluGen

CosMED Pharmaceuticals

Microdermics and OraSure Technologies

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Microneedle Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Microneedle Flu Vaccine, with price, sales, revenue and global market share of Microneedle Flu Vaccine from 2019 to 2021.

Chapter 3, the Microneedle Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Microneedle Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Microneedle Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Microneedle Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Microneedle Flu Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Microneedle Flu Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Solid Microneedle

1.2.3 Hollow Microneedle

1.2.4 Coated Microneedle

1.2.5 Dissolving Microneedle

1.3 Market Analysis by Application

1.3.1 Overview: Global Microneedle Flu Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Influenza A

1.3.3 Influenza B

1.4 Global Microneedle Flu Vaccine Market Size & Forecast

1.4.1 Global Microneedle Flu Vaccine Sales in Value (2016-2026))

1.4.2 Global Microneedle Flu Vaccine Sales in Volume (2016-2026)

1.4.3 Global Microneedle Flu Vaccine Price by Type (2016-2026) & (US$/Unit)

1.5 Global Microneedle Flu Vaccine Production Capacity Analysis

1.5.1 Global Microneedle Flu Vaccine Total Production Capacity (2016-2026)

1.5.2 Global Microneedle Flu Vaccine Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Microneedle Flu Vaccine Market Drivers

1.6.2 Microneedle Flu Vaccine Market Restraints

1.6.3 Microneedle Flu Vaccine Trends Analysis

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Sanofi Details

2.1.2 Sanofi Major Business

2.1.3 Sanofi Microneedle Flu Vaccine Product and Services

2.1.4 Sanofi Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 GC Pharma

2.2.1 GC Pharma Details

2.2.2 GC Pharma Major Business

2.2.3 GC Pharma Microneedle Flu Vaccine Product and Services

2.2.4 GC Pharma Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Debiotech

2.3.1 Debiotech Details

2.3.2 Debiotech Major Business

2.3.3 Debiotech Microneedle Flu Vaccine Product and Services

2.3.4 Debiotech Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 NanoPass Technologies

2.4.1 NanoPass Technologies Details

2.4.2 NanoPass Technologies Major Business

2.4.3 NanoPass Technologies Microneedle Flu Vaccine Product and Services

2.4.4 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Corium International

2.5.1 Corium International Details

2.5.2 Corium International Major Business

2.5.3 Corium International Microneedle Flu Vaccine Product and Services

2.5.4 Corium International Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Becton Dickinson and Company

2.6.1 Becton Dickinson and Company Details

2.6.2 Becton Dickinson and Company Major Business

2.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product and Services

2.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 FluGen

2.7.1 FluGen Details

2.7.2 FluGen Major Business

2.7.3 FluGen Microneedle Flu Vaccine Product and Services

2.7.4 FluGen Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 CosMED Pharmaceuticals

2.8.1 CosMED Pharmaceuticals Details

2.8.2 CosMED Pharmaceuticals Major Business

2.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services

2.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Microdermics and OraSure Technologies

2.9.1 Microdermics and OraSure Technologies Details

2.9.2 Microdermics and OraSure Technologies Major Business

2.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services

2.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Microneedle Flu Vaccine Sales by Manufacturer

3.1 Global Microneedle Flu Vaccine Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Microneedle Flu Vaccine Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Microneedle Flu Vaccine

3.4 Market Concentration Rate

3.4.1 Top 3 Microneedle Flu Vaccine Manufacturer Market Share

3.4.2 Top 6 Microneedle Flu Vaccine Manufacturer Market Share

3.5 Global Microneedle Flu Vaccine Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Microneedle Flu Vaccine Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Microneedle Flu Vaccine Market Size by Region

4.1.1 Global Microneedle Flu Vaccine Sales in Volume by Region (2016-2026)

4.1.2 Global Microneedle Flu Vaccine Revenue by Region (2016-2026)

4.2 North America Microneedle Flu Vaccine Revenue (2016-2026)

4.3 Europe Microneedle Flu Vaccine Revenue (2016-2026)

4.4 Asia-Pacific Microneedle Flu Vaccine Revenue (2016-2026)

4.5 South America Microneedle Flu Vaccine Revenue (2016-2026)

4.6 Middle East and Africa Microneedle Flu Vaccine Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Microneedle Flu Vaccine Sales in Volume by Type (2016-2026)

5.2 Global Microneedle Flu Vaccine Revenue by Type (2016-2026)

5.3 Global Microneedle Flu Vaccine Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Microneedle Flu Vaccine Sales in Volume by Application (2016-2026)

6.2 Global Microneedle Flu Vaccine Revenue by Application (2016-2026)

6.3 Global Microneedle Flu Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Microneedle Flu Vaccine Sales by Type (2016-2026)

7.2 North America Microneedle Flu Vaccine Sales by Application (2016-2026)

7.3 North America Microneedle Flu Vaccine Market Size by Country

7.3.1 North America Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)

7.3.2 North America Microneedle Flu Vaccine Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Microneedle Flu Vaccine Sales by Type (2016-2026)

8.2 Europe Microneedle Flu Vaccine Sales by Application (2016-2026)

8.3 Europe Microneedle Flu Vaccine Market Size by Country

8.3.1 Europe Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)

8.3.2 Europe Microneedle Flu Vaccine Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Microneedle Flu Vaccine Sales by Type (2016-2026)

9.2 Asia-Pacific Microneedle Flu Vaccine Sales by Application (2016-2026)

9.3 Asia-Pacific Microneedle Flu Vaccine Market Size by Region

9.3.1 Asia-Pacific Microneedle Flu Vaccine Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Microneedle Flu Vaccine Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Microneedle Flu Vaccine Sales by Type (2016-2026)

10.2 South America Microneedle Flu Vaccine Sales by Application (2016-2026)

10.3 South America Microneedle Flu Vaccine Market Size by Country

10.3.1 South America Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)

10.3.2 South America Microneedle Flu Vaccine Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Microneedle Flu Vaccine Sales by Type (2016-2026)

11.2 Middle East & Africa Microneedle Flu Vaccine Sales by Application (2016-2026)

11.3 Middle East & Africa Microneedle Flu Vaccine Market Size by Country

11.3.1 Middle East & Africa Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Microneedle Flu Vaccine Typical Distributors

12.3 Microneedle Flu Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Microneedle Flu Vaccine Revenue by Type, (USD Million), 2021-2026

Table 2. Global Microneedle Flu Vaccine Revenue by Application, (USD Million), 2021-2026

Table 3. Sanofi Basic Information, Manufacturing Base and Competitors

Table 4. Sanofi Major Business

Table 5. Sanofi Microneedle Flu Vaccine Product and Services

Table 6. Sanofi Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. GC Pharma Basic Information, Manufacturing Base and Competitors

Table 8. GC Pharma Major Business

Table 9. GC Pharma Microneedle Flu Vaccine Product and Services

Table 10. GC Pharma Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Debiotech Basic Information, Manufacturing Base and Competitors

Table 12. Debiotech Major Business

Table 13. Debiotech Microneedle Flu Vaccine Product and Services

Table 14. Debiotech Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. NanoPass Technologies Basic Information, Manufacturing Base and Competitors

Table 16. NanoPass Technologies Major Business

Table 17. NanoPass Technologies Microneedle Flu Vaccine Product and Services

Table 18. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Corium International Basic Information, Manufacturing Base and Competitors

Table 20. Corium International Major Business

Table 21. Corium International Microneedle Flu Vaccine Product and Services

Table 22. Corium International Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Becton Dickinson and Company Basic Information, Manufacturing Base and Competitors

Table 24. Becton Dickinson and Company Major Business

Table 25. Becton Dickinson and Company Microneedle Flu Vaccine Product and Services

Table 26. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. FluGen Basic Information, Manufacturing Base and Competitors

Table 28. FluGen Major Business

Table 29. FluGen Microneedle Flu Vaccine Product and Services

Table 30. FluGen Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. CosMED Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 32. CosMED Pharmaceuticals Major Business

Table 33. CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services

Table 34. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Microdermics and OraSure Technologies Basic Information, Manufacturing Base and Competitors

Table 36. Microdermics and OraSure Technologies Major Business

Table 37. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services

Table 38. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Global Microneedle Flu Vaccine Sales by Manufacturer (2019-2021e) & (K Units)

Table 40. Global Microneedle Flu Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 41. Market Position of Manufacturers in Microneedle Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 42. Global Microneedle Flu Vaccine Production Capacity by Company, (K Units): 2020 VS 2021

Table 43. Head Office and Microneedle Flu Vaccine Production Site of Key Manufacturer

Table 44. Microneedle Flu Vaccine New Entrant and Capacity Expansion Plans

Table 45. Microneedle Flu Vaccine Mergers & Acquisitions in the Past Five Years

Table 46. Global Microneedle Flu Vaccine Sales by Region (2016-2021e) & (K Units)

Table 47. Global Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units)

Table 48. Global Microneedle Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)

Table 49. Global Microneedle Flu Vaccine Revenue by Region (2021-2026) & (USD Million)

Table 50. Global Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)

Table 51. Global Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)

Table 52. Global Microneedle Flu Vaccine Revenue by Type (2016-2021e) & (USD Million)

Table 53. Global Microneedle Flu Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 54. Global Microneedle Flu Vaccine Price by Type (2016-2021e) & (US$/Unit)

Table 55. Global Microneedle Flu Vaccine Price by Type (2021-2026) & (US$/Unit)

Table 56. Global Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)

Table 57. Global Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)

Table 58. Global Microneedle Flu Vaccine Revenue by Application (2016-2021e) & (USD Million)

Table 59. Global Microneedle Flu Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 60. Global Microneedle Flu Vaccine Price by Application (2016-2021e) & (US$/Unit)

Table 61. Global Microneedle Flu Vaccine Price by Application (2021-2026) & (US$/Unit)

Table 62. North America Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)

Table 63. North America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)

Table 64. North America Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 65. North America Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 66. North America Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)

Table 67. North America Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)

Table 68. North America Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)

Table 69. North America Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)

Table 70. Europe Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)

Table 71. Europe Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)

Table 72. Europe Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 73. Europe Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 74. Europe Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)

Table 75. Europe Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)

Table 76. Europe Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)

Table 77. Europe Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)

Table 78. Asia-Pacific Microneedle Flu Vaccine Sales by Region (2016-2021e) & (K Units)

Table 79. Asia-Pacific Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units)

Table 80. Asia-Pacific Microneedle Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)

Table 81. Asia-Pacific Microneedle Flu Vaccine Revenue by Region (2021-2026) & (USD Million)

Table 82. Asia-Pacific Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)

Table 83. Asia-Pacific Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)

Table 84. Asia-Pacific Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)

Table 85. Asia-Pacific Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)

Table 86. South America Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)

Table 87. South America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)

Table 88. South America Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 89. South America Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 90. South America Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)

Table 91. South America Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)

Table 92. South America Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)

Table 93. South America Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)

Table 94. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)

Table 95. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)

Table 96. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 97. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 98. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)

Table 99. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)

Table 100. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)

Table 101. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)

Table 102. Direct Channel Pros & Cons

Table 103. Indirect Channel Pros & Cons

Table 104. Microneedle Flu Vaccine Typical Distributors

Table 105. Microneedle Flu Vaccine Typical Customers

List of Figures

Figure 1. Microneedle Flu Vaccine Picture

Figure 2. Global Microneedle Flu Vaccine Sales Market Share by Type in 2020

Figure 3. Solid Microneedle

Figure 4. Hollow Microneedle

Figure 5. Coated Microneedle

Figure 6. Dissolving Microneedle

Figure 7. Global Microneedle Flu Vaccine Sales Market Share by Application in 2020

Figure 8. Influenza A

Figure 9. Influenza B

Figure 10. Global Microneedle Flu Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 11. Global Microneedle Flu Vaccine Market Size and Forecast (2016-2026) & (USD Million)

Figure 12. Global Microneedle Flu Vaccine Sales (2016-2026) & (K Units)

Figure 13. Global Microneedle Flu Vaccine Price by Type (2016-2026) & (US$/Unit)

Figure 14. Global Microneedle Flu Vaccine Production Capacity (2016-2026) & (K Units)

Figure 15. Global Microneedle Flu Vaccine Production Capacity by Geographic Region: 2020 VS 2021

Figure 16. Microneedle Flu Vaccine Market Drivers

Figure 17. Microneedle Flu Vaccine Market Restraints

Figure 18. Microneedle Flu Vaccine Market Trends

Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Manufacturer in 2020

Figure 20. Global Microneedle Flu Vaccine Revenue Market Share by Manufacturer in 2020

Figure 21. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. Top 3 Microneedle Flu Vaccine Manufacturer (Revenue) Market Share in 2020

Figure 23. Top 6 Microneedle Flu Vaccine Manufacturer (Revenue) Market Share in 2020

Figure 24. Global Microneedle Flu Vaccine Sales Market Share by Region (2016-2026)

Figure 25. Global Microneedle Flu Vaccine Revenue Market Share by Region (2016-2026)

Figure 26. North America Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)

Figure 27. Europe Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)

Figure 28. Asia-Pacific Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)

Figure 29. South America Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)

Figure 30. Middle East & Africa Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)

Figure 31. Global Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)

Figure 32. Global Microneedle Flu Vaccine Revenue Market Share by Type (2016-2026)

Figure 33. Global Microneedle Flu Vaccine Price by Type (2016-2026) & (US$/Unit)

Figure 34. Global Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)

Figure 35. Global Microneedle Flu Vaccine Revenue Market Share by Application (2016-2026)

Figure 36. Global Microneedle Flu Vaccine Price by Application (2016-2026) & (US$/Unit)

Figure 37. North America Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)

Figure 38. North America Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)

Figure 39. North America Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)

Figure 40. North America Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)

Figure 41. United States Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)

Figure 45. Europe Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)

Figure 46. Europe Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)

Figure 47. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)

Figure 48. Germany Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Microneedle Flu Vaccine Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Microneedle Flu Vaccine Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Microneedle Flu Vaccine Revenue Market Share by Region (2016-2026)

Figure 57. China Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Korea Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)

Figure 64. South America Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)

Figure 65. South America Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)

Figure 66. South America Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)

Figure 67. Brazil Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)

Figure 70. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)

Figure 71. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)

Figure 72. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Egypt Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South Africa Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Sales Channel: Direct Channel vs Indirect Channel

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz